Pharmacokinetics of sunitinib in hemodialysis

Ann Oncol. 2009 Jan;20(1):190-2. doi: 10.1093/annonc/mdn626. Epub 2008 Sep 18.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacokinetics
  • Carcinoma, Renal Cell / complications
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / metabolism
  • Dose-Response Relationship, Drug
  • Humans
  • Indoles / administration & dosage*
  • Indoles / adverse effects
  • Indoles / pharmacokinetics*
  • Kidney Neoplasms / complications
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / metabolism
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Pyrroles / administration & dosage*
  • Pyrroles / adverse effects
  • Pyrroles / pharmacokinetics*
  • Renal Dialysis / methods*
  • Renal Insufficiency / etiology
  • Renal Insufficiency / therapy
  • Sunitinib
  • Young Adult

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib